From cell senescence to age-related diseases: differential mechanisms of action of senescence-associated secretory phenotypes

키워드

참고문헌 (99)

1. Chen D, "Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma", Clin Cancer Res, 17, pp.6693~6701 (2011)
2. Jones AW, "PGC-1 family coactivators and cell fate: roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signalling", Mitochondrion, 12, pp.86~99 (2012)
3. Chatrchyan S, "Measurement of the inclusive jet cross section in pp collisions at radicals = 7 TeV", Phys Rev Lett, 107, pp.132001~ (2011)
4. Sunderic M, "Protein molecular forms of insulin-like growth factor binding protein-2 change with aging", Exp Gerontol, 58, pp.154~158 (2014)
5. Minamino T, "Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction", Circulation, 105, pp.1541~1544 (2002)
6. Youdim MB, "The role of iron in senescence of dopaminergic neurons in Parkinson's disease", J Neural Transm Suppl, 40, pp.57~67 (1993)
7. Hengstler JG, "Oxidative stress: from modification of cell-cycle related events, secondary messenger function, dysregulation of small GTPases, protein kinases and phosphatases to redox-sensitive cancer models", Arch Toxicol, 82, pp.271~272 (2008)
8. Jones RM, "Interpretation and prediction of inhaled drug particle accumulation in the lung and its associated toxicity", Xenobiotica, 42, pp.86~93 (2012)
9. Hung WY, "Mitochondrial dysfunction promotes cell migration via reactive oxygen species-enhanced beta5-integrin expression in human gastric cancer SC-M1 cells", Biochim Biophys Acta, 1820, pp.1102~1110 (2012)
10. Hoffmeister A, "The HMG-I", Y-related protein p8 binds to p300 and Pax2 transactivation domain-interacting protein to regulate the transactivation activity of the Pax2A and Pax2B transcription factors on the glucagon gene promoter, 2002, pp.277, 22314~22319
11. Rohman L, "Chilaiditi's sign", Emerg Med J, 29, pp.86~ (2012)
12. Engelberg B, "Exploring minimally invasive options: managing demands, expectations, and outcomes", Dent Today, 31, pp.86~88 (2012)
13. West MD, "Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence", Exp Gerontol, 31, pp.175~193 (1996)
14. Lapierre LR, "Lessons from C. elegans:signaling pathways for longevity", Trends Endocrinol Metab, 23, pp.637~644 (2012)
15. Comi P, "Senescencedependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells", Exp Cell Res, 219, pp.304~308 (1995)
16. Sabharwal SS, "Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?", Nat Rev Cancer, 14, pp.709~721 (2014)
17. Ballinger SW, "Beyond retrograde and anterograde signalling: mitochondrial-nuclear interactions as a means for evolutionary adaptation and contemporary disease susceptibility", Biochem Soc Trans, 41, pp.111~117 (2013)
18. Dimri GP, "A biomarker that identifies senescent human cells in culture and in aging skin in vivo", Proc Natl Acad Sci U S A, 92, pp.9363~9367 (1995)
19. Bateman A, "The granulin gene family:from cancer to dementia", Bioessays, 31, pp.1245~1254 (2009)
20. Beckman KB, "Endogenous oxidative damage of mtDNA", Mutat Res, 424, pp.51~58 (1999)
21. Biswas G, "Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk", EMBO J, 18, pp.522~533 (1999)
22. Biswas G, "Mitochondria to nucleus stress signaling: a distinctive mechanism of NFkappaB", Rel activation through calcineurin-mediated inactivation of IkappaBbeta, 2003, pp.161, 507~519
23. Berneburg M, "'To repair or not to repair - no longer a question':repair of mitochondrial DNA shielding against age and cancer", Exp Dermatol, 15, pp.1005~1015 (2006)
24. He X, "Suppression of mitochondrial complex I influences cell metastatic properties", PLoS One, 8, pp.e61677~ (2013)
25. Boiteux S, "The human OGG1gene: structure, functions, and its implication in the process of carcinogenesis", Arch Biochem Biophys, 377, pp.1~8 (2000)
26. Brandon M, "Mitochondrial mutations in cancer", Oncogene, 25, pp.4647~4662 (2006)
27. Zhang YQ, "Expression and modification of ARC(apoptosis repressor with a CARD domain)is distinctly regulated by oxidative stress in cancer cells", J Cell Biochem, 104, pp.818~825 (2008)
28. Bogenhagen DF, "Enzymology of mitochondrial base excision repair", Prog Nucleic Acid Res Mol Biol, 68, pp.257~271 (2001)
29. Guettouche T, "Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress", BMC Biochem, 6, pp.4~ (2005)
30. Butow RA, "Mitochondrial signaling:the retrograde response", Mol Cell, 14, pp.1~15 (2004)
31. Byun HO, "GSK3 inactivation is involved in mitochondrial complex IV defect in transforming growth factor(TGF)beta1-induced senescence", Exp Cell Res, 318, pp.1808~1819 (2012)
32. Amuthan G, "Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells", Oncogene, 21, pp.7839~7849 (2002)
33. Byun HO, "Mitochondrial dysfunction by complex II inhibition delays overall cell cycle progression via reactive oxygen species production", J Cell Biochem, 104, pp.1747~1759 (2008)
34. Campagnoni CW, "Identification of genes in the oligodendrocyte lineage through the analysis of conditionally immortalized cell lines", Dev Neurosci, 23, pp.452~463 (2001)
35. Cano CE, "Nupr1 : the Swiss-knife of cancer", J Cell Physiol, 226, pp.1439~1443 (2011)
36. Carew JS, "Mitochondrial defects in cancer", Mol Cancer, 1, pp.9~ (2002)
37. Chae S, "A systems approach for decoding mitochondrial retrograde signaling pathways", Sci Signal, 6, pp.4~ (2013)
38. Chang CJ, "Mitochondrial dysfunction-induced amphiregulin upregulation mediates chemo-resistance and cell migration in HepG2 cells", Cell Mol Life Sci, 66, pp.1755~1765 (2009)
39. Chatterjee A, "Mitochondrial DNA mutations in human cancer", Oncogene, 25, pp.4663~4674 (2006)
40. Stein GH, "Molecular mechanisms for the senescent cell cycle arrest", J Investig Dermatol Symp Proc, 3, pp.14~18 (1998)
41. Hwang ES, "A comparative analysis of the cell biology of senescence and aging", Cell Mol Life Sci, 66, pp.2503~2524 (2009)
42. Cheung ST, "Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma", Clin Cancer Res, 10, pp.7629~7636 (2004)
43. Chowdhury UR, "Emerging role of nuclear protein 1(NUPR1)in cancer biology", Cancer Metastasis Rev, 28, pp.225~232 (2009)
44. Clayton DA, "Nuclear-mitochondrial intergenomic communication", Biofactors, 7, pp.203~205 (1998)
45. Cortopassi G, "Modelling the effects of age-related mtDNA mutation accumulation; complex I deficiency, superoxide and cell death", Biochim Biophys Acta, 1271, pp.171~176 (1995)
46. Kim YM, "Sterol regulatory element-binding protein(SREBP)-1-mediated lipogenesis is involved in cell senescence", J Biol Chem, 285, pp.29069~29077 (2010)
47. = 7 TeV, "Phys Rev Lett", 2011, 112001~
48. Czarnecka AM, "Mitochondrial DNA mutations in cancer--from bench to bedside", Front Biosci, 15, pp.437~460 (2010)
49. Seo M, "PFKFB3 regulates oxidative stress homeostasis via its S-glutathionylation in cancer", J Mol Biol, 426, pp.830~842 (2014)
50. Millis AJ, "Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts", Exp Cell Res, 201, pp.373~379 (1992)
51. Coppe JP, "Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor", PLoS Biol, 6, pp.2853~2868 (2008)
52. Imamura H, "Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy", J Hepatol, 38, pp.200~207 (2003)
53. Rodier F, "Four faces of cellular senescence", J Cell Biol, 192, pp.547~556 (2011)
54. Vital P, "The senescence-associated secretory phenotype promotes benign prostatic hyperplasia", Am J Pathol, 184, pp.721~731 (2014)
55. Han X, "Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function", Thromb Haemost, 113, pp.505~512 (2015)
56. Groppo R, "CPEB control of NF-kappaB nuclear localization and interleukin-6 production mediates cellular senescence", Mol Cell Biol, 31, pp.2707~2714 (2011)
57. Kulju KS, "Increased p53 protein associated with aging in human diploid fibroblasts", Exp Cell Res, 217, pp.336~345 (1995)
58. Salminen A, "Glycolysis links p53function with NF-kappaB signaling: impact on cancer and aging process", J Cell Physiol, 224, pp.1~6 (2010)
59. Brookes S, "Contribution of p16(INK4a)to replicative senescence of human fibroblasts", Exp Cell Res, 298, pp.549~559 (2004)
60. Delsite R, "Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells", Mol Cancer, 1, pp.6~ (2002)
61. Demorrow S, "Progranulin : a novel regulator of gastrointestinal cancer progression", Transl Gastrointest Cancer, 2, pp.145~151 (2013)
62. Di Bella D, "Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28", Nat Genet, 42, pp.313~321 (2010)
63. Dzierzbicki P, "Repair of oxidative damage in mitochondrial DNA of Saccharomyces cerevisiae: involvement of the MSH1-dependent pathway", DNA Repair (Amst), 3, pp.403~411 (2004)
64. DiMauro S, "Mitochondrial respiratory-chain diseases", N Engl J Med, 348, pp.2656~2668 (2003)
65. Encinar JA, "Human p8is a HMG-I", Y-like protein with DNA binding activity enhanced by phosphorylation, 2001, pp.276, 2742~2751
66. Finley LW, "The coordination of nuclear and mitochondrial communication during aging and calorie restriction", Ageing Res Rev, 8, pp.173~188 (2009)
67. Ashok BT, "Immunochemical detection of oxidative DNA damage in cancer and aging using anti-reactive oxygen species modified DNA monoclonal antibody", Int J Biochem Cell Biol, 30, pp.1367~1377 (1998)
68. Gardiner K, "Human genome organization", Curr Opin Genet Dev, 5, pp.315~322 (1995)
69. Goruppi S, "Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy", EMBO J, 21, pp.5427~5436 (2002)
70. Giroux V, "p8 is a new target of gemcitabine in pancreatic cancer cells", Clin Cancer Res, 12, pp.235~241 (2006)
71. Goruppi S, "The pro-hypertrophic basic helix-loop-helix protein p8 is degraded by the ubiquitin", proteasome system in a protein kinase B, J Biol Chem, pp.2004, 279[DOI]
72. Gredilla R, "Nuclear and mitochondrial DNA repair in selected eukaryotic aging model systems", Oxid Med Cell Longev, 2012, pp.282438~ (2012)
73. Grollman AP, "Mutagenesis by 8-oxoguanine:an enemy within", Trends Genet, 9, pp.246~249 (1993)
74. Guha M, "Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics", Mitochondrion, 13, pp.577~591 (2013)
75. Takahashi T, "Balloon-occluded retrograde transvenous obliteration for gastric varices in a child with extrahepatic portal venous obstruction", J Nippon Med Sch, 76, pp.173~178 (2009)
76. Hamidi T, "Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis", J Clin Invest, 122, pp.2092~2103 (2012)
77. Hamidi T, "Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death", Clin Cancer Res, 18, pp.5234~5246 (2012)
78. Haque A, "Lack of mitochondrial DNA enhances growth of hepatocellular carcinoma in vitro and in vivo", Hepatol Res, 36, pp.209~216 (2006)
79. Hashiguchi K, "The C-terminal alphaO helix of human Ogg1 is essential for 8-oxoguanine DNA glycosylase activity: the mitochondrial beta-Ogg1 lacks this domain and does not have glycosylase activity", Nucleic Acids Res, 32, pp.5596~5608 (2004)
80. Brew K, "Tissue inhibitors of metalloproteinases: evolution, structure and function", Biochim Biophys Acta, 1477, pp.267~283 (2000)
81. Reichenstein M, "ACTH induces TIMP-1 expression and inhibits collagenase in adrenal cortex cells", Mol Cell Endocrinol, 215, pp.109~114 (2004)
82. Binder BR, "Plasminogen activator inhibitor 1: physiological and pathophysiological roles", News Physiol Sci, 17, pp.56~61 (2002)
83. Alessi MC, "Plasminogen activator inhibitor-1, adipose tissue and insulin resistance", Curr Opin Lipidol, 18, pp.240~245 (2007)
84. Gils A, "The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors", Thromb Haemost, 91, pp.425~437 (2004)
85. Schroder WA, "The role of SerpinB2 in immunity", Crit Rev Immunol, 31, pp.15~30 (2011)
86. Hwa V, "The insulin-like growth factor-binding protein(IGFBP)superfamily", Endocr Rev, 20, pp.761~787 (1999)
87. Stewart CE, "Potentiation of insulin-like growth factor-I (IGF-I)activity by an antibody: supportive evidence for enhancement of IGF-I bioavailability in vivo by IGF binding proteins", Endocrinology, 133, pp.1462~1465 (1993)
88. Clemmons DR, "Role of insulin-like growth factor binding proteins in the control of IGF actions", Prog Growth Factor Res, 6, pp.357~366 (1995)
89. Orjalo AV, "Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6", IL-8 cytokine network, 2009, pp.106, 17031~17036
90. Kim YM, "Implications of time-series gene expression profiles of replicative senescence", Aging Cell, 12, pp.622~634 (2013)
91. Chow FL, "Many membrane proteins undergo ectodomain shedding by proteolytic cleavage. Does one sheddase do the job on all of these proteins?", IUBMB Life, 59, pp.44~47 (2007)
92. Hayashida K, "Molecular and cellular mechanisms of ectodomain shedding", Anat Rec (Hoboken), 293, pp.925~937 (2010)
93. Athauda G, "c-Met ectodomain shedding rate correlates with malignant potential", Clin Cancer Res, 12, pp.4154~4162 (2006)
94. Acosta JC, "A role for CXCR2 in senescence, but what about in cancer?", Cancer Res, 69, pp.2167~2170 (2009)
95. Freund A, "Inflammatory networks during cellular senescence: causes and consequences", Trends Mol Med, 16, pp.238~246 (2010)
96. Guo H, "Chemokine receptor CXCR2 is transactivated by p53 and induces p38-mediated cellular senescence in response to DNA damage", Aging Cell, 12, pp.1110~1121 (2013)
97. Kenyon C, "A C. elegans mutant that lives twice as long as wild type", Nature, 366, pp.461~464 (1993)
98. Elzi DJ, "Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stressinduced senescence", Proc Natl Acad Sci U S A, 109, pp.12052~12057 (2012)
99. Micutkova L, "Insulin-like growth factor binding protein-6 delays replicative senescence of human fibroblasts", Mech Ageing Dev, 132, pp.468~479 (2011)

관련 논문AI추천